Skip to content

CoMo Pharma

Active Risk: not assessed
General partnershipfounded 2026incorporated this yearWilgendreef 40, 8300 Knokke-Heist, BelgiumKBO/BCE: BE 1039.673.021
Summary

CoMo Pharma is younger than twelve months; there is no public track record yet to compute a bankruptcy probability from. The company has been active since 2026 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.

Articles of association

What the company does

DurationHow long the company exists; usually unlimited, so until it is dissolved.
Unlimited
Name clauseThe name the company operates under according to its articles.
CoMo Pharma
Legal form clauseThe legal form, such as BV, NV or CV, which decides which company-law rules apply.
Vennootschap onder firma
Registered office clauseThe region of the registered office; it decides among other things the language of official documents.
Geen, Vlaams Gewest

deed of 03-07-2026

Who represents it, and how

Board ruleHow the board is made up, meets and takes decisions.
Bepaalde of onbepaalde duur, één of meerdere zaakvoerders
Duur en ontslag zaakvoerder, algemene vergadering

deed of 03-07-2026

Meetings and financial year

Financial yearThe twelve-month period the company draws up its annual accounts for.
From 1 January to 31 December
Annual meetingWhen the shareholders meet each year, among other things to approve the annual accounts.
In June

deed of 03-07-2026

Other provisionsOther rules from the articles that fall under none of the themes above.

Other statement: Geen bijzondere verplichtingen, verslaggeving en revisorale controle bij inbreng in natura of nijverheid
Other statement: Aanwending resultaat, winstverdeling en reservevorming, algemene vergadering
Other statement: Overlijden,vereffening,faillissement,kennelijk onvermogen,wettelijke onbekwaamheid of verhindering zaakvoerder, tenzij algemene vergadering…

deed of 03-07-2026